MedPath

Haloperidol

Haloperidol Injection, USP

Approved
Approval ID

e2eed126-cb82-42b1-9b48-9cbeb6873b50

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 18, 2024

Manufacturers
FDA

Cardinal Health 107, LLC

DUNS: 118546603

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

HALOPERIDOL LACTATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55154-9553
Application NumberANDA075689
Product Classification
M
Marketing Category
C73584
G
Generic Name
HALOPERIDOL LACTATE
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateApril 27, 2020
FDA Product Classification

INGREDIENTS (4)

HALOPERIDOL LACTATEActive
Quantity: 5 mg in 1 mL
Code: 6387S86PK3
Classification: ACTIM
METHYLPARABENInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
LACTIC ACID, UNSPECIFIED FORMInactive
Code: 33X04XA5AT
Classification: IACT
PROPYLPARABENInactive
Quantity: 0.2 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Haloperidol - FDA Drug Approval Details